Loading clinical trials...
Loading clinical trials...
The primary aim of this study is to discover whether patients with CMT type 1 and 2 have neuromuscular junction transmission deficits. The secondary aim is to collect information of different clinica...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
NMD Pharma A/S
Collaborators
NCT06794489 · CMT1A, CMT (Charcot Marie Tooth Disease), and more
NCT01193088 · Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
NCT07049588 · Charcot-Marie-Tooth Disease Type 1A
NCT06881979 · Amyotrophic Lateral Sclerosis, Chronic Inflammatory Demyelinating Neuropathy, and more
NCT06203093 · Charcot-Marie-Tooth Disease, Healthy
Ohio State University
Columbus, Ohio
Aarhus University Hospital
Aarhus, Jutland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions